Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,425 USD | +12,79% |
|
-7,56% | -48,15% |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Stephen Willard
CEO | Chief Executive Officer | 63 | 12/07/22 |
Jonathan Javitt
FOU | Founder | 67 | 18/09/17 |
Richard Narido
DFI | Director of Finance/CFO | 46 | 13/09/23 |
Chief Tech/Sci/R&D Officer | - | 05/12/22 | |
Rick Panicucci
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Dennis McBride
BRD | Director/Board Member | 70 | 01/10/15 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jonathan Javitt
FOU | Founder | 67 | 18/09/17 |
Stephen Willard
CEO | Chief Executive Officer | 63 | 12/07/22 |
Janet Rehnquist
BRD | Director/Board Member | - | 27/12 |
Patrick J. Flynn
BRD | Director/Board Member | 75 | 24/05/21 |
Chaim Hurvitz
BRD | Director/Board Member | 64 | 24/05/21 |
Dennis McBride
BRD | Director/Board Member | 70 | 01/10/15 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 10 700 609 | 7 846 339 ( 73,33 %) | 0 | 73,33 % |
Azione B | 0 | 3 000 000 | 0 | 0 |
Coordinate società
![Indirizzo NRx Pharmaceuticals, Inc.(BRPA)](https://cdn.zonebourse.com/static/address/38908842.png)
Settore
![Consenso](/images/consensus_flch.gif)
Fatturato trimestrale - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
-48,15% | 23,06 Mln | |
+16,85% | 44,48 Mrd | |
+44,30% | 40,57 Mrd | |
-8,69% | 38,82 Mrd | |
+34,11% | 32,22 Mrd | |
-8,34% | 27,84 Mrd | |
+15,43% | 26,79 Mrd | |
+47,80% | 14,31 Mrd | |
+36,20% | 12,7 Mrd | |
-7,00% | 11,23 Mrd |
- Borsa valori
- Azioni
- Azione BRPA
- Società NRx Pharmaceuticals, Inc.